Search

Your search keyword '"Rebeiz, Abdallah G."' showing total 31 results
Start Over Author "Rebeiz, Abdallah G."
31 results on '"Rebeiz, Abdallah G."'

4. Corrigendum to A-41 | Percutaneous Coronary Intervention With Procedural Unfractionated Heparin Without Activated Clotting Time Guidance: A Unique Opportunity to Assess Thrombotic and Bleeding Events [Journal of the Society for Cardiovascular Angiography & Interventions, 2(3S), 100705]

Author

Zgheib, Ali Z., primary, Jdaidani, Jennifer, additional, Akl, Elie, additional, Khalil, Suzan, additional, Chaabo, Omar, additional, Piazza, Nicolo, additional, Sawaya, Fadi J., additional, and Rebeiz, Abdallah G., additional

Published
2024
Full Text
View/download PDF

19. The I allele of the angiotensin converting enzyme I/D polymorphism confers protection against coronary artery disease

Author

Abchee, Antoine, El-Sibai, Mirvat, Youhanna, Sonia, Yeretzian, Joumana S., Hanine, Estephan, Makhoul, Nadine J., Puzantian, Houry, Sawaya, Jaber, Nasrallah, Antoine, Rebeiz, Abdallah G., Zreik, Tony G., Azar, Sami T., Zalloua, Pierre A., Abchee, Antoine, El-Sibai, Mirvat, Youhanna, Sonia, Yeretzian, Joumana S., Hanine, Estephan, Makhoul, Nadine J., Puzantian, Houry, Sawaya, Jaber, Nasrallah, Antoine, Rebeiz, Abdallah G., Zreik, Tony G., Azar, Sami T., and Zalloua, Pierre A.

Abstract

Background: Mutations in genes regulating lipid metabolism, vasoactivity, and coagulation are important modulators of coronary artery disease (CAD). Objective: This study investigated the association between allelic variants of the angiotensin converting enzyme (ACE), methytetrahydrofolate reductase, plasminogen activator inhibitor-1 and factor V genes and CAD. Methods: Clinical, biochemical, and angiographic information were collected from 300 patients who underwent cardiac catheterization and their DNA was genotyped by restriction fragment length polymorphism. Results: The frequency of the D allele of the ACE gene was significantly higher than the I allele in patients with more than 70% stenosis in any vessel. Among patients with more than 70% stenosis, carriers of the D allele were 2.8 times more likely to be males. The presence of the ACE I allele was negatively associated with CAD with (P=0.02 ,OR=0.38.) Conclusion: This study describes a protective role of the ACE I allele in individuals who may be at risk of developing CAD.

Published
2017

21. The I allele of the angiotensin converting enzyme I/D polymorphism confers protection against coronary artery disease

Author

Abchee, Antoine, primary, El-Sibai, Mirvat, additional, Youhanna, Sonia, additional, Yeretzian, Joumana S., additional, Estephan, Hanine, additional, Makhoul, Nadine J., additional, Puzantian, Houry, additional, Sawaya, Jaber, additional, Nasrallah, Antoine, additional, Rebeiz, Abdallah G., additional, Zreik, Tony G., additional, Azar, Sami T., additional, and Zalloua, Pierre A., additional

Published
2010
Full Text
View/download PDF

22. Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)

Author

Rebeiz, Abdallah G., primary, Johanson, Per, additional, Green, Cindy L., additional, Crater, Suzanne W., additional, Roe, Matthew T., additional, Langer, Anatoly, additional, Giugliano, Robert P., additional, Lincoff, A. Michael, additional, Newby, L. Kristin, additional, Harrington, Robert A., additional, Topol, Eric J., additional, Califf, Robert M., additional, Wagner, Galen S., additional, and Krucoff, Mitchell W., additional

Published
2005
Full Text
View/download PDF

24. Optimal duration of eptifibatide infusion in percutaneous coronary intervention (An ESPRIT substudy)

Author

Rebeiz, Abdallah G., primary, Dery, Jean-Pierre, additional, Tsiatis, Anastasios A., additional, O'Shea, J. Conor, additional, Johnson, Brent A., additional, Hellkamp, Anne S., additional, Pieper, Karen S., additional, Gilchrist, Ian C., additional, Slater, James, additional, Muhlestein, J. Brent, additional, Joseph, Diane, additional, Kitt, Michael M., additional, and Tcheng, James E., additional

Published
2004
Full Text
View/download PDF

26. Contrast Nephropathy

Author

Kandzari, David E, primary, Rebeiz, Abdallah G, additional, Wang, Andrew, additional, and Sketch, Michael H, additional

Published
2003
Full Text
View/download PDF

28. Outcomes of Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention and Medical Therapy for Multivessel Disease with and without Left Ventricular Dysfunction.

Author

Kpodonu, Jacques, Rebeiz, Abdallah G., Evans, Alexander, Geha, Alexander S., Caines, Amitra E. B., and Massad, Malek G.

Subjects
*CORONARY artery bypass, *SURGICAL stents, *CORONARY disease, *CONGESTIVE heart failure
Abstract

Multiple randomized trials support the treatment of patients with multivessel coronary artery disease (CAD) and relatively normal left ventricular (LV) ejection fraction (EF) by either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). However, there has been a paucity of trials in the recent literature that have compared the outcomes of patients with multivessel CAD and low EF who undergo PCI or CABG. This review examines some of the clinical trials and series in this subgroup of patients and also compares the outcome of patients undergoing either procedure in the absence and presence of LV dysfunction. These trials and series support the notion that PCI can be successfully performed in patients with low EF with relatively low mortality, but that CABG is associated with greater freedom from repeat revascularization and from angina or congestive heart failure symptoms. In addition, most of the data published thus far indicate a long-term survival advantage among patients with ventricular dysfunction who have undergone CABG. Further studies, including randomized trials incorporating the evolving techniques of CABG and the recent advances in PCI, will be needed to assess the proper role and outcome of these two interventions. Copyright © 2004 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]

Published
2004
Full Text
View/download PDF

30. The role of high sensitivity C-reactive protein in coronary artery disease risk prediction: a review.

Author

Abou Diwan CH, Oghlakian GO, Antonios SI, Otrock ZK, and Rebeiz AG

Subjects
Aspirin therapeutic use, Clinical Trials as Topic, Cohort Studies, Confidence Intervals, Coronary Disease prevention & control, Female, Humans, Hypolipidemic Agents therapeutic use, Male, Nephelometry and Turbidimetry methods, Odds Ratio, Platelet Aggregation Inhibitors therapeutic use, Predictive Value of Tests, Primary Prevention, Prognosis, Prospective Studies, Risk, Risk Assessment, Risk Factors, Sensitivity and Specificity, Sex Factors, C-Reactive Protein analysis, Coronary Disease blood, Coronary Disease epidemiology
Published
2004

31. Radiocontrast nephropathy: a time for affirmative action.

Author

Rebeiz AG, Kandzari DE, Wang A, and Sketch MH Jr

Subjects
Female, Humans, Kidney Diseases epidemiology, Male, Risk Factors, Sex Factors, Contrast Media adverse effects, Kidney Diseases chemically induced
Published
2003

Catalog

Books, media, physical & digital resources
See catalog results